Pediatric Neuromotor Clinic Print E-mail

Intensive Occupational Therapy (based upon ACQUIREc model of Pediatric Constraint-Induced Movement Therapy)

Welcome to the UAB Pediatric Neuromotor Clinic, currently under the direction of Reggi Lutenbacher, MS, OTR/L. We are pleased to offer Intensive Occupational Therapy, with constraint, to assist children with neuromotor disorders.  This treatment is based upon twelve years of research and clinical application using the ACQUIREc form of pediatric constraint-induced movement therapy.  The word Acquire exemplifies the overall goal of this intensive occupational therapy treatment--to acquire new skills and function for children participating in this therapy while the subscript c indicates the important component of casting.
 

Dr. Stephanie DeLuca and Dr. Karen Echols, former researchers at the UAB Civitan International Research Center and Sparks Clinics, led the way in developing this promising therapy.  We are excited to continue offering this intensive occupational therapy based on the ACQUIREc research and clinical findings.

Please contact Reggi Lutenbacher, MS, OTR/L, Director of Intensive Occupational Therapy:  An ACQUIREc Therapy Model, for further information and questions regarding treatment options that may be beneficial for your child.  Please see the attached Brochure of Services to to select the Therapy Protocol most appropriate for your child.

Donations made be made to the Pediatric Neuromotor Clinic by clicking on this link, choosing the School of Medicine, and the Pediatric Neuromotor Donations.  Please note that donations may not be directed to support a specific child receiving any services.  
 
Contact Us:
Reggi Lutenbacher, MS, OTR/L, Director
This e-mail address is being protected from spambots. You need JavaScript enabled to view it    

Direct Phone:  205-975-0466
Toll Free:  1-800-822-2472, Option 8


Attachments:

1.  Treatment Information:  a. Description of Services      

2.  Evidence Base for Treatment:  a.  Randomized Controlled Trial   b.  Multi-Site Multi-Dose Study